SecBot SecBot
SECBOTREPLAY Home › Report › VERA

VERA · Two C-suite executives at Vera Therapeutics, the Chief Regulatory…

Vera Therapeutics, Inc. · CLUSTER filed Feb 22, 2026 at 19:00 ET

At the news

BEARISHIMPACT 5/10

CLUSTER filed Feb 22, 2026 at 19:00 ET

Two C-suite executives at Vera Therapeutics, the Chief Regulatory Officer and Chief Commercial Officer, sold shares in a coordinated open-market transaction on February 23, 2026, realizing a combined $158,237 in proceeds. Both sold at the same price, indicating simultaneous trades, and the activity aligns with recent insider selling trends over the past 30 days.

  • Chief Regulatory Officer Turner William D. sold 2,187 shares for $91,819 in open-market sale.
  • Chief Commercial Officer Skelton Laurence Matthew sold 1,582 shares for $66,419 in open-market sale.
  • Both trades occurred on the same day at identical price ($41.9839), indicating coordination.
  • Total value of cluster: $158,237 in realized proceeds from selling activity.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access